Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free IRD Stock Alerts

Opus Genetics (IRD) Earnings Date, Estimates & Call Transcripts

Opus Genetics logo
$3.66 -0.06 (-1.61%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$3.59 -0.07 (-1.91%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Opus Genetics Earnings Summary

Opus Genetics released Q2 2026 earnings on August 6, 2026, reporting an EPS of -$0.14, which beat analysts' consensus estimates of -$0.16 by $0.02. Quarterly revenue was reported to be $0.76 million, below analyst estimates of $2.63 million. With a trailing EPS of -$1.35, Opus Genetics' earnings are expected to grow next year, from ($1.09) to ($0.78) per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
-$0.16
Actual EPS
(Aug. 6)
-$0.14 Beat By $0.02
Actual Revenue
(Aug. 6)
$0.76M

Q2 2026 Earnings Resources

Powered by Quartr
Get Opus Genetics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Opus Genetics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IRD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Opus Genetics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.16-$0.14-$0.15
Q2 20263-$0.18-$0.15-$0.17
Q3 20263-$0.18-$0.15-$0.16
Q4 20263-$0.14-$0.06-$0.11

Opus Genetics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026-$0.1567-$0.14+$0.0167-$0.14$2.63M$0.76M
5/12/2026Q1 2026-$0.16-$0.75 -$0.59-$0.75$2.93M$2.16M
11/12/2025Q3 2025-$0.14-$0.12+$0.02-$0.25$3.07M$3.08M
8/13/2025Q2 2025-$0.25-$0.12+$0.13-$0.12$4.27M$2.88M
5/15/2025Q1 2025-$0.34-$0.32+$0.02-$0.24$4.00M$4.30M
3/31/2025Q4 2024-$0.34-$1.27 -$0.93-$1.27$11.10M$3.40M
11/12/2024--$0.30-$0.29+$0.01-$0.29$1.17M$3.87M

Opus Genetics Earnings - Frequently Asked Questions

Opus Genetics (NASDAQ:IRD) last announced its quarterly earning data on Thursday, August 6, 2026. Learn more on IRD's earnings history.

In the previous quarter, Opus Genetics (NASDAQ:IRD) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.02. Learn more on analysts' earnings estimate vs. IRD's actual earnings.

Opus Genetics (NASDAQ:IRD) has a recorded annual revenue of $14.20 million.

Opus Genetics (NASDAQ:IRD) has a recorded net income of -$49.59 million. IRD has generated -$1.35 earnings per share over the last four quarters.

Opus Genetics' earnings are expected to grow from ($1.09) per share to ($0.78) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:IRD is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel